Hindustan_Construction_Company%E0%A4%B9%E0%A4%BF%E0%A4%A8%E0%A5%8D%E0%A4%A6%E0%A5%81%E0%A4%B8%E0%A5%8D%E0%A4%A4%E0%A4%BE%E0%A4%A8_%E0%A4%95%E0%A4%82%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A4%95%E0%A5%8D%E0%A4%B6%E0%A4%A8_%E0%A4%95%E0%A4%82%E0%A4%AA%E0%A4%A8%E0%A5%80%E0%B4%B9%E0%B4%BF%E0%B4%A8%E0%B5%8D%E0%B4%A6%E0%B5%81%E0%B4%B8%E0%B5%8D%E0%B4%A5%E0%B4%BE%E0%B5%BB_%E0%B4%95%E0%B5%BA%E0%B4%B8%E0%B5%8D%E0%B4%9F%E0%B5%8D%E0%B4%B0%E0%B4%95%E0%B5%8D%E0%B4%B7%E0%B5%BB_%E0%B4%95%E0%B4%AE%E0%B5%8D%E0%B4%AA%E0%B4%A8%E0%B4%BFHindustan_Construction_CompanyQ12460488
about
sameAs
Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinomaPerilipin 5 and Lipocalin 2 Expression in Hepatocellular CarcinomaCyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinomaFAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinomaSUMOylation regulates LKB1 localization and its oncogenic activity in liver cancerLncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signalingPeri-tumor fibroblasts promote tumorigenesis and metastasis of hepatocellular carcinoma via Interleukin6/STAT3 signaling pathwayDelivery of selective internal radiation therapy complicated by variant hepatic vascular anatomySNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysisThe Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma ProgressionEqual treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyMDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathwayCirculating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the LiverROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma CellsNCR group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma developmentLong non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinomaCellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome ProfilingFBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlationHippo Signaling in the Liver - A Long and Ever-Expanding StoryFOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular CarcinomaHigh Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular CarcinomaCombined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentTreatment of Naïve HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection TACE Followed by RadiotherapyAssociation of serum interferon-λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct-acting antiviral agentsPromising diagnostic and prognostic value of E2Fs in human hepatocellular carcinomaStudying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi PatientsUtility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experienceEpigenetics of hepatocellular carcinomaObservational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular CarcinomaLINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling PathwayTheranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive ProceduresYAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic RoleGATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genesSELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian CohortPalbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response
P921
Q37477277-F40E1D00-4453-4FE3-BEF2-CE21A9EDBE72Q62734387-7CC8CC67-EE92-42AD-869C-4F57062959EBQ62734440-B3C99BC4-74EF-41FF-BBE3-C4E0B50F1926Q63246531-43F9D1B8-BBBD-4F0C-84C8-86C25420C262Q63884152-8C03303E-1DE1-4FD2-818C-F16765907D6CQ64054077-79C5BD96-DEA1-4F15-AA94-325D40935518Q64058113-85E7F9CB-357F-4DCA-9C8B-D42CD87410AAQ64059091-8A34306A-7843-4586-9743-084EF925C7DCQ64063161-75A30BB1-357E-4040-91D5-9BCBB20AA363Q64064543-34B9E096-3EAC-4E26-937D-A0FD6EB6D0F8Q64066777-AAE4234D-2DCB-4BB5-905D-39B461AB7E14Q64067150-5A2904A7-E4AD-46DB-B8AE-F20CDA9777D9Q64071299-4CAC2DC2-7A52-4439-8B06-6BED5AD7AB6AQ64071936-E84C7BBB-8C7E-4CA2-907D-B5FCCDB17D45Q64075903-E3D6C98D-8D50-4DB2-AFE9-25831C87EFA6Q64081252-1168A4BF-94E8-4D06-8F15-88FD534C9CEBQ64087578-7C8A208A-EAAE-472E-9311-E1F32DEB271AQ64101710-E367D45D-54C4-435B-A87C-F8C5B6906E4DQ64101758-06927198-6912-48FE-BDA2-C4B9458119E5Q64102115-B74B7D4C-F4F0-4553-A8FD-EF6F3BA83223Q64106002-7FAC276D-9C1E-42ED-B1A6-40DE4275A116Q64108464-044AADAC-7384-4890-8680-C978833D0426Q64111271-B36122AB-8094-41AD-9AA1-B1AB9059A3EFQ64123186-FD6465B8-1E53-4CD5-AE6F-ABB097274FADQ64133040-E82D0D05-756C-4472-8321-D5F3230E5999Q64228137-7981F26D-013C-4E9A-A3EB-928297287E14Q64235731-ADBD0B1E-562F-4169-B61F-658800291795Q64236816-9BD731C4-FB70-40FC-9ED5-934A9ACBAE09Q64240700-7DE005B4-8E99-4E91-A82B-487C3F7D6187Q64244125-9E83AA5D-95C8-455C-A99D-53D6B261BC50Q64245246-77E7F691-3F54-4063-868C-B4B91DBF3C5CQ64259929-369F9E66-E274-49FE-9BAA-AA7C2D7CD16FQ64273870-12190E8E-C44D-4A1B-960C-34581A951FC2Q64279553-36A79F6A-C952-4BA3-B5A5-3AECEB240964Q64374976-EC469218-2011-475C-88A4-0102B765EB60Q64389075-416E4406-27B9-4437-8208-B6895C638CD4
P921
description
construction and civil engineering company in India
@en
name
HCC
@en
Hindustan Construction Company
@fr
Hindustan Construction Company
@nb
हिन्दुस्तान कंस्ट्रक्शन कंपनी
@hi
ഹിന്ദുസ്ഥാൻ കൺസ്ട്രക്ഷൻ കമ്പനി
@ml
印度斯坦建筑公司
@zh-cn
印度斯坦建筑公司
@zh-hans
印度斯坦建築公司
@zh
印度斯坦建築公司
@zh-hant
type
label
HCC
@en
Hindustan Construction Company
@fr
Hindustan Construction Company
@nb
हिन्दुस्तान कंस्ट्रक्शन कंपनी
@hi
ഹിന്ദുസ്ഥാൻ കൺസ്ട്രക്ഷൻ കമ്പനി
@ml
印度斯坦建筑公司
@zh-cn
印度斯坦建筑公司
@zh-hans
印度斯坦建築公司
@zh
印度斯坦建築公司
@zh-hant
altLabel
Hindustan Construction Company
@ml
印度斯坦建筑公司
@zh
prefLabel
HCC
@en
Hindustan Construction Company
@fr
Hindustan Construction Company
@nb
हिन्दुस्तान कंस्ट्रक्शन कंपनी
@hi
ഹിന്ദുസ്ഥാൻ കൺസ്ട്രക്ഷൻ കമ്പനി
@ml
印度斯坦建筑公司
@zh-cn
印度斯坦建筑公司
@zh-hans
印度斯坦建築公司
@zh
印度斯坦建築公司
@zh-hant
P159
P31
P3417
Hindustan-Construction-Company
P571
1926-01-01T00:00:00Z